Patients with PFIC2 with BSEP3 subtype mutations have higher incidence of HCC compared with less severe genotypes [4], necessitating careful screening in these patients via twice-yearly AFP tests and ultrasound [2,27]. The gene discussed is ABCB11; the disease is hepatocellular carcinoma.